Podcasts about Accreditation

"If you are considering board service, I would say take the leap. Start with your local chapter. It will give you some valuable skills that will help prepare you when you are applying for your national level. And I always say, if you want to do it, just do it because what's the worst that can happen? They can say no, but that doesn't mean that you will never serve on a board. I always tell people delayed is not denied," Cassandra Green, DNP, RN, OCN®, ONS member and past president of the Oncology Nursing Certification Corporation (ONCC) Board of Directors, told Evelyn Wempe, DNP, MBA, APRN, ACNP-BC, AOCNP®, CRN, NEA-BC, chair of the ONS Leadership Succession Committee (formerly known as the Leadership Development Committee), during a conversation about service on a board of directors. Wempe spoke with Green and ONS members Kristin Ferguson, DNP, MBA, RN, OCN®, CGNC, former treasurer and director-at-large on the ONS Board of Directors, and Yanka Campbell, DNP, RN, CPHQ, AGPCNP-BC, CNE, member of the Oncology Nursing Foundation (ONF) Board of Directors, about their experiences with board service. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 28, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to serving on a board of directors for a professional organization. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Meet the ONS Board of Directors series Episode 342: What It's Like to Serve on the Leadership Development Committee ONS Voice articles: Could Today Be the Start of Your ONS Leadership Journey? Nursing Leadership Unlocked Leading With Purpose Creates a Vision for the Future of Oncology Nursing ONS courses: A Guide to Chapter Leadership: Chapter President Training Board Leadership: Nurses in Governance Clinical Journal of Oncology Nursing article: Rearview Mirror Leadership: Looking Backward to Move Forward ONS Board Self-Assessment ONS Leadership ONCC Board of Directors ONF Leadership Your Roadmap to Future Service on the ONS Board of Directors ONS Leadership Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Campbell: "Joining a board was a natural next step for me to maintain my connection to bedside nursing that I've loved for so many years, and to find a way to give back to advanced practice nurses as well in this role. The Oncology Nursing Society and Foundation were especially meaningful for me because I knew firsthand the importance of having scholarship, research, funding, and leadership development programs that can really change the trajectory of a nurse's career. I realized I wanted to help shape the opportunities that were available to me for future nurses, and I just did not want to continue to do that through one-on-one mentorships, which I have done extensively throughout my career, but find a way to help more broadly toward guiding organizational mission and strategic objectives." TS 7:20 Green: "Everyone was so welcoming on the board. Everyone was so friendly. One of the first things I remember our executive director Tony Ellis telling me is, 'Most of our new board members are really quiet and reserved at our first meeting. They just kind of keep things to themselves. They don't ask a lot of questions.' I don't know if they were prepared for me because I came in with guns a-blazing, and I had lots of questions. I was not quiet. I was very involved and very vocal. I still am, but that was one of the best experiences ever. Before that, I had never really been in a board setting other than my local chapter, and even then, I was just starting to be in that setting because I was the president of my local chapter and on the [ONCC] Board of Directors at the same time." TS 10:29 Ferguson: "A nonclinical mentor I would absolutely identify would be Alec Stone, who used to be the ONS director of public affairs. … He helped me to learn a lot about health policy and advocacy and the impact a nurse's voice can have. Learning how to speak about my experiences in health care in public by doing programs like the Nurses in Washington Internship … or ONS's Capitol Hill Days ended up giving me a lot more confidence that I didn't know I would have in expressing my point of view and being very open and collegial and expressing my opinions. … This really lent itself well to my future board experience because, as Cassandra mentioned, board members have to speak their mind and speak up at the meetings." TS 12:11 Campbell: "One of the most unexpected benefits was when I reached out to my executive leadership team at the Kimmel Cancer Center at Johns Hopkins and said, 'I'm being considered to serve on the ONF Board. This is going to require me taking time away from work to attend meetings, to attend some in-person meetings. And then it would be really wonderful at the institution if I'm able to also financially impact the nurses who need to benefit from what I've benefited from in my career.' Usually when you have those conversations, you are expecting to present a deck of PowerPoint slides to make your case, but the answer from my leadership team in participating in ONF and supporting the Board was an immediate yes. It was 'Yes, when can you start? Yes, what can we do to support you?' And really making sure that I had dedicated time to be fully present." TS 14:15 Ferguson: "There are many skills and experiences that can lend themselves to being a strong board member. … The ability to speak your mind clearly and express your thoughts, which really boils down to strong communication skills. We are lucky in our careers. We all have worked as nurses in different settings and health care, and nurses are naturally skilled and good at communication. We learn strategies like SBAR—situation, background assessment, recommendation. Nurses every day are communicating in their places of work, oftentimes with patients who are sick and need education, or perhaps with new nurses they're teaching or mentoring. And they are communicating with non-nurses, as well, and nonpatients, so clinical roles and nonclinical roles. So nurses already have a good understanding of best practices when it comes to communication, and this can lend itself well to any board position." TS 21:04 Green: "When you [come into a] leadership role, I think that's when we learn most about ourselves and what we expect. And be the leader type of leader that you want to be and the type of leader that you would like to work with so that you can make your experience valuable and pleasurable." TS 28:57

Today's Headlines: It was quite a weekend! Trump turned DC streets into a 1.7-mile IndyCar speedway for another Freedom 250 event, took a ceremonial lap in the presidential limo with Melania — not Natalie — while his Qatari plane did a flyover. In other shady news, Trump announced he's importing up to 300,000 metric tons of "product for ground beef" without specifying what the product is, where it's from, or how it'll be discounted 25% — which landed one day after a New York Times investigation revealed the Bureau of Land Management has been selling wild horses to buyers who ship them to slaughter plants through a legal loophole, with sales more than doubling in 2025. On the tariff beat, The trade war with Canada is officially back on with 50% tariffs on $20 billion in goods, Canadian PM Mark Carney promising to match them dollar for dollar starting September 8th, and Carney publicly stating that Trump is demanding Canada change its French language and Quebec culture as conditions for reversing tariffs. We finally have a nominee to lead the FDA, Trump nominated Dr. Heidi Overton and she has an MD and a PhD, which is more than expected. She has also called for conservatives to "infiltrate" public health institutions though, which is less reassuring given that 2026 has already seen four times the average number of foodborne illness cases. The Department of Education took the first steps to strip the American Bar Association of its law school accreditation authority, which would prevent graduates of non-accredited schools from sitting the bar exam in most states — a creative way to destabilize the entire legal profession. Back to shady, Jared Kushner quietly met with Democratic leader Hakeem Jeffries to discuss working together on housing and cost of living, which suggests the White House privately expects Democrats to win the House majority in November. And finally, a wildfire near Reno has burned over 13,000 acres with zero containment, putting 42,000 people under evacuation orders including two hospitals, with 40 additional fires burning across Nevada simultaneously. Resources/Articles mentioned:  CNN: Freedom 250 IndyCar race in Washington, DC, and other Trump administration news CNN: Trump defends pause on beef tariffs amid criticism from US cattle producers Variety: Taylor Sheridan Accused of Stealing ‘Yellowstone' From 2016 Pitch in Copyright Lawsuit NYT: Under Trump, Protected Wild Horses Are Going to Slaughter Time: Who Is Heidi Overton, Trump's Nominee to Lead the FDA? AP News: What to know about Trump's 50% tariffs on Canadian goods that just went into effect WSJ: Trump Administration Attacks Bar Association's Power to Accredit Law Schools AP News: Jared Kushner meets with Democratic leader Jeffries with House control at stake in November NYT: Fire Near Reno, Nev., Prompts Evacuations of Homes and Hospitals Subscribe to the Betches News Room and join the Morning Announcements group chat. Go to: betchesnews.substack.com Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

Download your free LSAT cheat sheet here: https://swiy.co/KFMPXZwWC7k I scored a 152 my first LSAT. Got to a 175. I've been teaching this test since 2005. If you're prelaw, applying now, or stuck, you're in the right place.

"They're really worried that radiation is going to be painful. So they come in for that first day of treatment very anxious. With our patients with brain cancer, we're using the masks on the table, and those masks are very tight and hold their heads very, very still. So they'll be very worried about being claustrophobic. We may start out the first day or two with a little bit of [lorazepam]. And they'll come to me and they'll say, 'This really hasn't been as bad as I thought it was going to be,'" ONS member Catherine McCluskey, BSN, RN, OCN®, ROCN™, radiation oncology staff nurse at Atrium Health Wake Forest Baptist in Winston-Salem, NC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, who was the manager of oncology nursing practice at ONS at the time of the recording, during a conversation about radiation side effects in central nervous system (CNS) cancers. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 21, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat CNS cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Radiation Site-Specific Side Effects series Episode 306: Cancer Symptom Management Basics: CNS Toxicities ONS Voice articles: Augmented Reality Simulations Reduce Patient Anxiety by Teaching Them About Radiation Therapy CNS Survivorship Needs More Research, Funding, and Training, Expert Panel Says Here's What the Updated CTCAE Version 6.0 Means for Oncology Nurses Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: Indications of Targeted Radiotherapy to the Brain and Spine: 2025 ONS Congress® Session ONS ROCN™ Certification Review™ ONS/ONCC® Radiation Therapy Certificate™ Supporting Radiation Side Effect Management Through ONS Evidence-Based Resources: 2025 ONS Congress® Session Clinical Journal of Oncology Nursing articles: Implementing a Standardized Educational Tool for Patients With Brain Tumors Undergoing Concurrent Temozolomide and Radiation Therapy Radiation Necrosis: A Differential Diagnosis Dilemma The Neurocognitive Late Effects of Cranial Radiation Therapy: The Often-Unrecognized Outcomes Oncology Nursing Forum article: Symptom Clusters in Patients With Brain Tumors Undergoing Proton Beam Therapy ONS Huddle Cards: External Beam Radiation Proton Therapy Proton Therapy Radiation ONS Guidelines™ and Symptom Management Resources Cognitive impairment Fatigue Mucositis Radiodermatitis ONCC resources: Big List of CE Radiation Oncology Certified Nurse (ROCN™) Common Terminology Criteria for Adverse Events (CTCAE v6.0) Patient Health Questionnaire (PHQ-9 and PHQ-2) To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "With primary tumors—glioblastomas, astrocytoma, all of those types of cancerous primary CNS tumors, the tumors are not very well-defined. They have little tentacles that kind of go out, so doing something like Gamma Knife, which is very precise, is not as effective as an external beam because the external beam will deliver radiation to all those little tentacles that are out there in the brain. And with Gamma Knife, you really can't effectively do that." TS 2:34 "When we're doing radiation to the brain, fortunately there aren't that many acute toxicities involved. Sometimes they'll have some mild dermatitis. Usually, it's not very significant. They, like everyone else who gets radiation, will have fatigue. Usually once we get to the end of the second week of radiation, into the third week for our patients with primary CNS tumors—the hair loss—they'll start to notice hair loss just in the treatment area. But those are typical, the things that we've seen most. Sometimes we'll have patients who will experience some nausea, maybe a few headaches, but really the acute toxicities are not severe typically with our patients with brain tumors." TS 8:30 "[For] the fatigue, I tell patients to just listen to their bodies. We don't want them to be sedentary, and we want them to go out and continue living their lives. But I do warn them that the fatigue is pretty much common to all patients receiving radiation at various degrees, depending on the patient. I just tell them to do what they feel like doing, and then when they're tired to rest, and if they find themselves having a nap in the afternoon, that's okay." TS 13:51 "What I find with these patients in particular is that a lot of times, their first symptoms related to any type of cancer are CNS symptoms from brain metastasis. Our patients with lung cancer or melanoma—they come in through the emergency room for altered mental status or seizures or something like that. They find a mass in their brain, and then they find a mass on their lung, or they find masses everywhere. Typically, they want to treat the brain masses first before they start them on any kind of systemic treatment. And so, they'll come to us, and they're in shock. Everything's happened very quickly. They haven't had a chance to really catch their breath. They're overwhelmed. And so I try to make sure they understand that everyone that they see here is part of their team and is with them through this journey and they're not alone." TS 25:36 "A couple of years ago, ONS put out an email asking for people to volunteer to do a delineation study about the feasibility of doing a radiation oncology certified nursing exam. And I, just on a whim, responded to that email. It's not something I've ever done before, and thinking that I would not be put on the team. … And I thought, 'I don't have enough experience, I don't know what I'm doing, and they won't choose me.' And lo and behold, they put me on this role delineation study. … I have met so many incredible nurses with all kinds of experience. I've learned so much. It has opened up a lot of things for me and it's been really exciting, so all I can do is say take advantage of those opportunities when they come. Don't think that you don't know enough, because you know more than you think you do." TS 32:38 

Coach Blu dives into the complex and often problematic world of youth residential treatment programs in the United States, with a focus on Utah. He shares personal experiences, industry history, regulatory challenges, and the need for reform to better serve youth and families. Chapters 00:00 Introduction and Purpose of the Episode 01:14 Coach Blu's Personal Connection to Treatment Programs 02:24 Focus on Youth Residential Treatment in the US 03:13 Historical Development of Youth Treatment Movement 04:09 Problems with Traditional Treatment Approaches 05:02 Industry Profitability and Oversight Issues 06:26 Exposing Shady Practices and Investigations 08:06 Case Study: Provo Canyon and Paris Hilton 09:33 Infiltrating Treatment Centers and Industry Flaws 11:00 Evolution of Youth Treatment Facilities 13:09 Growth in the 1980s and 1990s 14:35 Profit Motives and Public Funding 16:22 Fragmentation and Lack of Unified Standards 18:05 Historical Roots and State Involvement 19:57 Expansion and Industry Growth in the 80s and 90s 22:17 Private Industry and Marketing Strategies 24:12 Oversight, Accreditation, and Quality Control 27:04 Utah's Role as a Treatment Hub 33:28 Controversies in Wilderness and Outdoor Programs 36:43 Regulation and Oversight Improvements 38:09 Why Utah Became a Major Treatment Center 41:57 Children's Limited Contact and Therapeutic Impact 43:20 Behavioral Modification and Family Dynamics 50:24 Parenting Challenges and Systemic Issues 52:17 Long-term Effects and Adult Voices 54:40 The Need for Systemic Reform and Future Outlook 01:06:16 Upcoming Episodes and Call for Change

"Measurable residual disease is where I think the terminology fits best in that, it is intended to measure the amount of cancer cells that are present in the blood or bone marrow at the time the sample was collected. We can identify one cancer cell in a million. Where that can be really valuable is when we start to think about the duration of treatments and the response to some of our treatments," ONS member Caitilin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about chronic lymphocytic leukemia (CLL) treatment considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD), including 45 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by August 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to treatment of chronic lymphocytic leukemia. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 422: An Overview of Chronic Lymphocytic Leukemia for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis Episode 184: Oncologic Emergencies 101: Tumor Lysis Syndrome ONS Voice articles: Fixed-Duration Therapy for CLL May Lower Cardiovascular Risks and Costs Less Than Continuous Treatment Individuals With CLL Face Increased Risk for Skin Cancer Master Hypersensitivity Reactions With These Strategies for Prevention and Management Patients With CLL Report Worse QoL and Other Factors Clinical Journal of Oncology Nursing articles:  Acalabrutinib: Nursing Considerations for Use in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Pseudohyperkalemia in Chronic Lymphocytic Leukemia: An Often Overlooked Clinical Entity Richter Transformation Arising From Chronic Lymphocytic Leukemia Venetoclax: Management and Care for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia ONS book: Site-Specific Cancer Series: Leukemia (first edition) ONS symptom management resources:  Fatigue Prevention of Bleeding Prevention of Infection: General Blood Cancer United: Chronic Lymphocytic Leukemia Treatment CLL Society: Patient Education Toolkit Lymphoma Research Foundation: Lymphoma Treatments Patient education sheets Acalabrutinib Ibrutinib Pirtobrutinib To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Blood work is a really nice way to evaluate if there is progression of the disease. And we evaluate their blood counts, specifically that complete blood count with a differential. We anticipate an elevated white count, and we anticipate that the absolute lymphocyte count is going to be elevated. That's characteristic of the disease. But what evolves and happens is that those numbers can rapidly change and what we get concerned about is if that white count—and the percentage of the absolute lymphocyte count specifically—starts to increase and double quickly." TS 5:52 "There are some components that help clinicians decide if we expect these things, this cadence of change to happen more readily, or if we feel really comfortable that the biology of the variants contributing to the type of CLL that each patient may have, they may not have that progression as quickly or at all. And so that kind of helps us in that follow-up and cadence. Oftentimes, we're checking blood work every three or six months. Some patients are on an annual interval of visits depending on that active surveillance. I think the other piece is that we have a relatively low threshold when there is a change in symptoms to just recheck those blood tests. It's nice that we can have a pretty readily available blood test to be able to give us a lot of information for these patients." TS 9:45 "When we think about CLL therapy, the old tried and true [treatments] still work: so, rituximab and obinutuzumab. And then we kind of start to think about pathways and the way, the mechanisms of which these treatments are integrated. We think about different pathways of how we can induce cell death, but also what are the potential side effects? What are the potential interactions?" TS 19:35 "I think a lot of this is about really having a clear understanding of the patient's goals and really being able to understand and align. I think we have a lot more data to provide guidance for those patients that really are wanting to know: What is my chance of overall survival? If I do this, does this mean that I don't need to ever be on treatment again? If I do it this way, does it mean that I have to come into clinic every week, or does it mean that I have to come in every week but I'm done? I do one year of treatment, and I don't have to think about treatment for a really long time based on some of these components that we can take into consideration." TS 24:36 "When we think about the B-cell lymphoma 2 (BCL-2) inhibitors, with venetoclax, I think the biggest component we think about is tumor lysis syndrome. It's so effective that these cancer cells release all of those electrolytes, potassium, phosphorus; you can see a rise in the lactate dehydrogenase and uric acid because those cells are breaking down. And so subsequently, that leads us to the consideration of, is the patient's kidney function able to clear it? And so a lot of frequent lab monitoring, a lot of hydration, supportive care with medications like ursodiol or allopurinol to really improve the ability to clear that cellular waste product so that it doesn't cause an oncologic emergency." TS 34:11

In this episode of the InspirED Podcast, Andrea De La Cerda explores what it means to become the main character in your own story. Through personal reflections on growing up in a conservative religious environment, navigating marriage, corporate leadership, and burnout, she shares how many of us unknowingly live according to expectations we never consciously chose. Drawing on psychology, personal development, and real-life examples, Andrea explains why so many women become supporting characters in their own lives and how reclaiming authorship begins with small, intentional choices. This episode is an invitation to stop waiting for permission, trust your own voice, and begin writing the next chapter on your own terms....CHAPTERS00:44 Reclaiming Your Story03:15 The Impact of External Scripts05:46 The Hero's Journey08:16 Signs You're a Supporting Character10:46 Taking Back the Pen...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠⁠⁠⁠The InspirED Rewrite⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Darrell Daniel, UVM Program Manager at SMUD, joins Trees & Lines to break down how his team built the only right-of-way stewardship accredited program at a public power utility. Darrell walks through the growth mindset that's driven a decade of improvement, how SMUD separates real AI capability from vendor hype, the goat grazing program that's become a community favorite, and the biggest misconception utility leadership has about vegetation management: that once you clear it, you're done. Subscribe now to stay updated: https://linktr.ee/treesandlinespodcast #UtilityVegetationManagement #RightOfWay #UtilityForestry #PublicPower #TreesAndLines Hosted on Acast. See acast.com/privacy for more information.

Send us a text and chime in!With plans of becoming a teacher, Yavapai College's Director of Academic Initiatives Megan Crossfield obtained a bachelor's degree in early childhood education and then secured a master's in education with an emphasis in counseling and student personnel. She's in the final stages of pursuing a doctorate in higher education leadership, which she hopes to complete in January or February. Crossfield has been working in the field of higher education since approximately 2013, all at community colleges. “I love working in community college because it's open access,” Crossfield said. “If there's any student, anyone that wants to further their education, gain...   For the written story, read here >> https://www.signalsaz.com/articles/yavapai-college-director-supports-accreditation-and-student-access/ Check out the CAST11.com Website at: https://CAST11.com Follow the CAST11 Podcast Network on Facebook at: https://Facebook.com/CAST11AZFollow Cast11 Instagram at: https://www.instagram.com/cast11_podcast_network

In this episode of the NASP Podcast, Sheila Arquette, R.Ph., President & CEO of the National Association of Specialty Pharmacy (NASP), sits down with Dr. Caroline Girardeau, PharmD, MBA, PMP, BCPS, Pharmacy Program Director at the Accreditation Commission for Health Care (ACHC), to explore the evolving specialty pharmacy accreditation landscape. Together, they discuss the scope and value of comprehensive specialty pharmacy accreditation, examining how rigorous accreditation standards help improve patient safety, clinical outcomes, operational excellence, and the overall quality of care. They also highlight how specialty pharmacies can leverage accreditation as more than a requirement for participation in payer or limited distribution networks, using it as a strategic framework to drive continuous quality improvement, strengthen operations, and elevate the patient experience.

Navigating Common Shoulder Injuries in Youth Athletes Evaluation and Credit:  Evaluation and Credit:  https://www.surveymonkey.com/r/medchat93 Target Audience This activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast will review the diagnosis and management of shoulder pain in youth athletes - which is a common musculoskeletal complaint. Items addressed will address common shoulder injuries and highlight key features in the diagnosis as well as red flags. Objectives  Identify the most common shoulder injuries in youth and adolescent athletes and differentiate overuse injuries from acute traumatic injuries. Review the pathology, diagnosis and management of common shoulder pain and injuries in youth athletes, including the red flags. List factors that contribute to overuse injuries in youth athletes. Discuss strategies to reduce shoulder injury risk in youth athletes as well as outlining expectations for recovery and return to play. Moderator Monalisa Tailor, M.D. Internist Norton Community Medical Associates - Barret Louisville, KY Speaker Caleb Davis, M.D. Orthopedic Surgeon Norton Orthopedic Institute Louisville, KY Planners, Moderator and Speaker Disclosure  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose. Commercial Support There was no commercial support for this activity.  Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Resources for Additional Study/References Childhood and Adolescent Sports-Related Overuse Injuries https://pubmed.ncbi.nlm.nih.gov/38215415/ Overuse Injuries, Overtraining, and Burnout in Young Athletes https://pubmed.ncbi.nlm.nih.gov/38247370/   Date of Original Release | Aug 2026; Information is current as of the time of recording.  Course Termination Date | Aug 2029 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

"A good way of thinking about this is this is the survival of the fittest clone. There could be a portion of a cancer that naturally has some resistance or ability to survive a particular drug. And over time, as the other cells around it are dying off, that particular clone is able to replicate and continue to survive in the face of that drug therapy and eventually take over as being the fittest clone. At that point, we're often seeing disease progression," Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about resistance pathways.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 30 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by August 7, 2027. Roman has served on advisory boards for Genetech, Pfizer, Regeneron, and Daiichi Sankyo and received honoraria payments from Pharmacy Times and Decera for faculty lectures. These financial relationships have been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge related to resistance pathways in oncology care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 423: Pharmacology 101: Interaction Pathways Episode 406: Drug Resistance Biomarkers and Their Impact on Cancer Treatment Choices ONS Voice articles: Predictive and Diagnostic Biomarkers Scientists Identify Protein Implicated in Tumor Growth, Treatment Resistance ONS book: Guide to Cancer Immunotherapy (second edition) Genomics and Precision Oncology Learning Library ONS Biomarker Database Pharmacogenomics Huddle Card CancerQuest: Cancer Drug Resistance National Comprehensive Cancer Network OncoKB.org Research To Practice To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "As we look at drug resistance, this is the concept that cancer cells are no longer able to respond to a cancer treatment. The downstream of this is that we could end up with progression of the disease and need to look at alternative therapies that may be beneficial for the patient. This is unfortunately a very common phenomenon. Drug resistance is a major cause of treatment failure and poor patient outcomes with treatments. Unfortunately, this is an issue we see that increases over time on treatment." TS 2:29 "Genetics play a really big role in drug resistance. We know that drug resistance can be due to different things. It could be epigenetics. It could be the tumor microenvironment factors. But genetics often play a very big role in resistance pathways. It's generally considered to be a critical contributor to resistance, particularly in the way of acquired variants to drug targets or amplifications of certain oncogenes that can lead cancers to have progression. A well-known genetic alteration is the BRCA1/BRCA2 variant that helps to make the cancer more efficient at fixing DNA damage. So we're trying to get DNA damage with chemotherapy, and this particular variant helps at fixing that damage to allow the cancer to progress. So that is one genetic variant we see that plays a big role in a number of different cancers." TS 4:51 "These pathways are not mutually exclusive. Oftentimes we have multiple resistance pathways involved. I think it's important to understand some of those individually, but kind of thinking about this as we might be facing multiple resistance pathways. ... We can see resistance mechanisms that vary based on the type of treatment we use, for example, traditional cytotoxic chemotherapy. We may be more likely to see some resistance mechanisms that are working at DNA: repairing broken DNA or working on those efflux pumps that are being used to push chemotherapy out of cells. If we're talking more about the targeted therapies such as tyrosine kinase inhibitors or monoclonal antibodies, we may be more likely to see resistance mechanisms that are what we discussed with that drug target alteration: changing the way that the target agents are able to bind to the tumor cells to activate or inactivate pathways so we may see some changes there." TS 12:39 "One way to overcome this and to help to decrease the resistance from developing is using combination therapy: drugs that are targeting different pathways at once or potentially using combinations with things like chemotherapy in addition to immunotherapy. In this way, as we're getting these different targets, we can hopefully decrease the mechanism of resistance that may be developing." TS 14:48 "Biomarker testing is an incredibly important part of our practice. In many situations now, we are getting upfront, comprehensive biomarker testing to identify whether the patient may have any of those intrinsic or primary resistance mechanisms that might make it so a patient is never going to respond to a particular type of treatment. And in that case, we can spare the patient from the potential toxicities of that treatment if we don't think that there's going to be benefit there. So I think that that has become a really important way that we can tailor patients for understanding what treatments are going to be more effective. And then after that, there's usually additional biomarker testing that may be warranted at the time of progression in certain types of cancer. And that really helps us to understand that acquired resistance that might be developing." TS 17:32 "Nurses are really helpful with filling in the gaps and bringing back patient concerns that might be shared with them. And these might be early signs of progression. Better understanding how our patients are feeling and what's going on with them may help us to identify a patient that we need to do some additional testing for to understand whether there is drug resistance ongoing and potential progression of disease." TS 21:52

The clinical elements of an EMS program are vast and complicated but essential.  What can a clinical coordinator do to help students succeed? Hosts Maia Dorsett and Hilary Gates sit down with Michael Miller, EdD, RN, NRP, Associate Director, Committee on Accreditation of Educational Programs for the EMS Professions (CoAEMSP) and Tim "Hutch" Hutchings, EMT-P, Clinical Coordinator, Monroe Community College Paramedic Program, to unpack the sometimes invisible role of the clinical coordinator. Mike presents the CoAEMSP accreditation standards and the four core clinical coordinator responsibilities, while Hutch shares hard-won, real-world strategies for building trust with students and preceptors alike. Together they explore what separates good clinical coordination from great, why relationships matter more than spreadsheets, common barriers faced by EMS programs, and creative solutions for ensuring quality clinical placements. A must-listen for program directors, educators, and anyone coordinating clinical experiences in EMS education.Ginger Locke highlights the episode's key points with her "Mindset Minute."Mentioned in the episode:CoAEMSP INTERPRETATIONS OF THE CAAHEP 2023 STANDARDS AND GUIDELINEShttps://coaemsp.org/wp-content/uploads/2025/06/Interpretations-of-the-2023-CAAHEP-Standards.pdfThe EMS Educator is published on the first Friday of every month! Be sure to turn on your notifications so you can listen as soon as the episode drops, and like/follow us on your favorite platform.Check out the Prodigy EMS Bounty Program! Earn $1000 for your best talks!Get your CE at www.prodigyems.com. Follow @ProdigyEMS on FB, YouTube, TikTok & IG.

Most people believe entrepreneurship is about building a successful business. Andrea De La Cerda believes it's about building yourself. In this episode of the InspirED Podcast, Andrea explores how entrepreneurship exposes the beliefs, fears, and identity patterns that shape every decision we make. Through personal stories of burnout, corporate leadership, and rebuilding her own life, she shares why businesses often stall because of identity rather than strategy. You'll discover how your relationship with money, confidence, boundaries, and self-worth directly influences your business—and why becoming the person capable of leading your vision is the greatest work of all. Whether you're launching your first business or leading an established organization, this conversation will challenge you to see entrepreneurship as one of life's greatest opportunities for personal transformation....CHAPTERS00:00 Introduction to Energy and Life02:42 Understanding Energy Investment05:14 The Impact of Relationships on Energy07:28 Finding Purpose Through Energy Alignment09:57 Shifting Attention for Future Transformation...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠⁠The InspirED Rewrite⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

What if the way we measure competence in dental hygiene education is missing the bigger picture?   In this episode of A Tale of Two Hygienists, Jessica and Dave sit down with Sara Taft to explore how data can transform dental hygiene education. From simplifying accreditation to uncovering meaningful trends in student performance, Sara shares how technology is helping educators move beyond compliance and toward truly understanding student growth.   Whether you're preparing for CODA accreditation or looking for better ways to assess clinical competence, this conversation offers practical insights into the future of dental hygiene education.   In This Episode   The challenge that inspired a better approach to student assessment.   How technology helps measure competence beyond traditional grading.   Surprising trends and insights programs have uncovered through their data.   Using objective data while preserving the human side of teaching and mentorship.   Practical advice for educators navigating assessment and accreditation.   The future of educational technology in dental hygiene.   The one metric every dental hygiene program should be tracking.   Connect with Our Guest   Sara Taft Email: sara.taft@upscaleassessment.com LinkedIn: https://www.linkedin.com/in/sara-taft-08a83476/   Contact the Hosts   Jessica Atkinson Email: jatkinson@endeavorb2b.com   Dave Torres Email: dtorres@endeavorb2b.com

What if the way we measure competence in dental hygiene education is missing the bigger picture?   In this episode of A Tale of Two Hygienists, Jessica and Dave sit down with Sara Taft to explore how data can transform dental hygiene education. From simplifying accreditation to uncovering meaningful trends in student performance, Sara shares how technology is helping educators move beyond compliance and toward truly understanding student growth.   Whether you're preparing for CODA accreditation or looking for better ways to assess clinical competence, this conversation offers practical insights into the future of dental hygiene education.   In This Episode   The challenge that inspired a better approach to student assessment.   How technology helps measure competence beyond traditional grading.   Surprising trends and insights programs have uncovered through their data.   Using objective data while preserving the human side of teaching and mentorship.   Practical advice for educators navigating assessment and accreditation.   The future of educational technology in dental hygiene.   The one metric every dental hygiene program should be tracking.   Connect with Our Guest   Sara Taft Email: sara.taft@upscaleassessment.com LinkedIn: https://www.linkedin.com/in/sara-taft-08a83476/   Contact the Hosts   Jessica Atkinson Email: jatkinson@endeavorb2b.com   Dave Torres Email: dtorres@endeavorb2b.com

In this segment of "Cancer Registry World," three oncology data specialists discuss how their work as NCRA representatives and liaisons brings the ODS perspective to cancer staging education, accreditation standards, quality measures, cancer program requirements, and coding. Joining the conversation are Juliet Hinton Kolin, ODS-C, BSB, MBA, Cancer Registry Manager of Research and Informatics at FGH Cancer Center; Carrie A. Antonelli, BA, ODS-C, Oncology Data and Accreditation Manager at Sarah Cannon Cancer Network and NCRA liaison to the Commission on Cancer; and Penne J. Perry, RHIT, ODS-C, Senior Manager of Oncology Data and Accreditation at Sarah Cannon Cancer Network and NCRA representative to the National Accreditation Program for Breast Centers. Please enjoy listening and learning.  

"When people with PTSD [post-traumatic stress disorder] get quite avoidant—and that can be expressed in so many different ways—the implications can be really profound. I think an important invitation to oncologists and oncology nurses and primary care providers who care for people battling cancer is let's explore what's underneath these avoidant behaviors. Is it a very practical thing? Or is it that underneath this avoidant behavior is really profound fear?" James C. Jackson, PsyD, research professor at Vanderbilt University Medical Center in Nashville, TN, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about addressing medical trauma in oncology. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 31, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to medical trauma in oncology care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 421: Medical Trauma in Oncology Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care Episode 264: Stop the Stressors and Improve Your Mental Health as a Nurse ONS Voice articles: Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD [post-traumatic stress disorder] Past Trauma Lowers Hope, QOL, and Coping Ability During Cancer Managing Cancer-Related PTSD Starts With Acknowledgement Moral Injury and Trauma in Nursing Trauma-Informed Care Provides Person-Centered Support for Patients During Deep Distress Clinical Journal of Oncology Nursing articles: How Can a Trauma-Informed Care Approach Be Applied to Patients With Gynecologic Cancer? Psychosocial Barriers to Care: Recognizing and Responding Through a Trauma-Informed Care Approach Oncology Nursing Forum articles: Post-Traumatic Distress and Symptom Experience in Patients With Head and Neck Cancer–Related Tracheostomy and Family Caregivers The Effect of Neuroticism, Fear of Progression, and Self-Efficacy on Post-Traumatic Growth in Patients With Lung Cancer Undergoing Chemotherapy The Relationship Between Colorectal Cancer Survivors' Positive Psychology, Symptom Characteristics, and Prior Trauma During Acute Cancer Survivorship ONS course: Psychosocial Dimensions of Cancer Care™ ONS Huddle Card: Coping Screening tools Clinician-Administered PTSD Scale for DSM-5 [Diagnostic and Statistical Manual of Mental Disorders, 5th edition] (CAPS-5) Hospital Anxiety and Depression Scale Primary Care PTSD Screen for DSM-5 PTSD Checklist for DSM-5 Trauma Screening Questionnaire International Society for Traumatic Stress Studies: Free Resources PESI Reclaiming Your Life From Medical Trauma by James C. Jackson To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "For many people who have been traumatized, if they can avoid it, they will. They may not avoid the annual evaluation that is so hugely consequential—they might not avoid that. But they may well avoid a routine visit for a checkup to their oncologist. They very well may avoid a visit with a psychologist who is wanting them to talk about hard things. They may avoid visiting a friend in the hospital because it reminds them of really upsetting things. So, this issue of adherence and compliance is a really big problem." TS 3:19 "Screening tools for things like PTSD can be very useful. They're quite practical, and they're appropriate to use. I really like something called the Post-Traumatic Stress Disorder Checklist. ... Using it is going to be very straightforward. You're going to want to map it onto a 30-day window, and you're going to employ it with patients. It's a 20-item self-report. It assesses 20 DSM-5 symptoms of PTSD. It's not diagnostic, but if people score in this range of 30, 31, 33, we typically are going to believe that that is very suggestive of significant PTSD." TS 9:17 "One of the things we should be doing all the time is modeling and attempting to normalize this idea of being open about mental health difficulties. When I say modeling, this is a complicated issue. ... I'm very open talking about my own battles with mental health. And in some ways, that invites my patients to do the same. I don't recommend necessarily that a nurse says, 'Oh, by the way, I have PTSD. I'm going to tell you about mine. I want you to tell me about yours.' That's a boundary issue. But I think it does behoove us as clinicians to create a culture as much as we're able, where we can talk about mental health difficulties in a matter-of-fact way, acknowledging that mental health is health. These tools, to me, go a long way in that direction." TS 13:41 "The survivorship process is ongoing. I think a nurse can assist a patient in so many ways longitudinally over time. ... One of those ways is to continue checking on mental health outcomes in patients. Continuing to check on mental health outcomes, continuing to explore them, and continuing to invite patients to talk about things that other people might not be asking about. It's easy for family members to assume, 'Hey, you know, you're cancer free now. You look fine, so you must be fine.' It's very possible that the patients we're talking about are not fine. They're far from fine. For that oncology nurse at a follow-up clinic or in an oncology setting to talk about this, continuing to affirm that it would be okay for patients to struggle, continuing to put this issue on a front burner—I think that's really important." TS 21:17 "I'm aware of nurse-led support groups where nurses can talk very freely about their own challenges, in a safe space. ... Working to build cultures in the context of the intensive care unit, let's say, where we have a lot of patients with cancer that prioritize well-being nurse driven programs. ...  The bottom line is if there is a warning light that is blinking, nurses need to attend to that. And in attending to it, they're going to be more present for their patient. They're going to be better able to support their patient. They're going to be better able to support each other. And I think often, in the culture of nursing and psychology, too, people just put their head down, their shoulder down, and they just plow through in ways that are really counter to their mental health." TS 29:56 "The truth is medical trauma can be well-managed. It's not simple. It's not always intuitive. There are all sorts of caveats with regard to this, but the truth is people with medical trauma can live really rich and meaningful lives. ... So, the default setting, I think, should be not one of pessimism. It should be that people with medical trauma can and do get better. If you are a patient with medical trauma and you are in my purview, until proven differently, I'm going to assume that you can get better too." TS 36:28

RecLess - ReRelease of Season 3 Ep 1 - Jen Basham, Director of Parks and Recreation, Burleson, TX; speaks to her philospohy and systems for building culture, promoting and developing leaders from within, and hiring and promoting, while juggling maternity leave. She also speaks to her experience working in agencies of varying sizes and needs, and her experience as a Commission for Accreditation of Park and Recreation Agencies (CAPRA) Review Team member. Click here to learn more about CAPRA - https://www.nrpa.org/certification/accreditation/CAPRA/Shane Mize is the Director of Parks and Recreation in the city of Pflugerville, Texas, where he resides with his wife and children.Tom Venniro is the 12-year Director of Parks and Recreation in Hilton-Parma, New York, where he resides with his wife Melissa, son Jack, and daughters Amelia and Maisie.Jay Tryon is an 19-year park and recreation professional who loves to improve communities and their quality of life. He currently resides in Charlotte, North Carolina, with his wife and children.

In this episode of the InspirED Podcast, Andrea De La Cerda challenges the belief that success comes from working harder. Drawing from her own experience with corporate leadership, entrepreneurship, and burnout, she explores how hustle culture often rewards exhaustion instead of effectiveness. Andrea shares why alignment—not constant busyness—is the true competitive advantage, explaining how values, purpose, relationships, and work must move in the same direction to create lasting fulfillment and meaningful results. Through research, personal stories, and practical reflection questions, this episode invites listeners to redefine success and build lives rooted in intention instead of obligation....CHAPTERS00:00 Introduction to Energy and Life02:42 Understanding Energy Investment05:14 The Impact of Relationships on Energy07:28 Finding Purpose Through Energy Alignment09:57 Shifting Attention for Future Transformation...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠⁠The InspirED Rewrite⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

It's YOUR time to #EdUp with Dr. Meagan Mielczarek, Director of Assessment & Accreditation, East Stroudsburg UniversityIn this episode, recorded LIVE from the 2026 AcOps Conference powered by CoursedogYOUR host is Dr. Joe Sallustio⁠⁠⁠⁠⁠⁠Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!

Discover why IDA Accreditation PLUS is the gold standard for dyslexia teacher training. Learn how structured literacy, supervised practicums, and performance assessments create educators who transform reading outcomes for struggling students. Newman University City: Wichita Address: 3100 McCormick Website: https://newmanu.edu/

"In oncology specifically, where care is complex, artificial intelligence (AI) can really synthesize large volumes of clinical information, flag risks such as treatment complications, and support adherence to evidence-based pathways. For nurses specifically, this enables them more time for direct patient care, clinical judgment, and care coordination, and really practice to the top of their license while reducing repetitive time and administrative tasks," Jenn Frith, DNP, RN, OCN®, NE-BC, associate vice president of clinical operations at Duke Cancer Institute in Durham, NC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS. Weimer spoke with Frith and Emily Norboge, director of clinical and research informatics at Duke Cancer Institute, about how AI can help healthcare organizations improve the cancer experience.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 24, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of artificial intelligence in oncology nursing practice. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 284: How AI Is Influencing Cancer Care and Oncology Nursing Episode 281: Nursing's Role in AI in Health Care ONS Voice articles: Human Connection Creates the Power Behind AI in Nursing If You're Using AI in Health Care, Your Patients Want to Know Majority of Adults Use AI, But Most Distrust Accuracy of Health Information Nurses Are Key to Quality for AI Tools in Oncology Care One-Third of Hospitals Have Integrated Generative AI Into EHRs, With More to Follow Clinical Journal of Oncology Nursing articles: A Case for Caution: Patient Use of Artificial Intelligence Artificial Intelligence in Oncology Nursing: Preparing the Workforce for the Future Artificial Intelligence: Basics, Impact, and How Nurses Can Contribute Integrating Artificial Intelligence Into Cancer Care: Enhancing Nursing Practice and Bridging Disparities Oncology Nursing Forum article: Artificial Intelligence for Oncology Nursing Authors: Potential Utility and Concerns About Large Language Model Chatbots To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Norboge: "Our AI voice agent has a series of workflows that it can execute. ... If a patient needs help with medical paperwork, the agent will walk the patient through how to do that paperwork. If a patient has a question that they need sent to their provider, it can document that and then send a message to the provider. There's a series of workflows so it can route to scheduling. It can answer information about test results that is compliant with our policy around test results. The goal of that agent is that it will handle all of those administrative-type tasks that don't necessarily require a nurse to fill." TS 5:44 Norboge: "When [patients] call the nurse triage line, the nurse will have to say, 'I understand you want your test results. I can contact your provider and have them reach out to you about your results.' But that's kind of where it ends. What we worked out with the agent is if a patient calls and says, 'I really want my test results,' they will in a very nice, standard way, say something similar. You know, 'I'm not authorized to discuss your test results with you, but I'd be happy to send a message to your provider and ask them to call you.' But then the agent goes one step further and says, 'Are you experiencing anxiety about your test results? If so, I can transfer you to the nurse to discuss support for a potential referral to family medical therapy if you would like help managing that anxiety.' In a clear, helpful way, it can define and help a patient with their needs and not just have a standard of 'this is our policy and I can't share it with you.'" TS 11:14 Frith: "Really, transparency is the key. The patient should understand that AI is used more as an enhancement, but not to replace the human connection. That's not the goal. The nurses can explain that the tools will help ensure accuracy, timeliness, and safety while allowing more time for the direct interaction of the nurse. I think framing AI as an additional layer of support rather than a decision maker helps build trust. And I think maintaining strong communication and presence at the bedside just reinforces that care remains fundamentally human." TS 15:32 Frith: "I think AI in oncology is going to continue to advance in our predictive analytics, personal care planning, and probably real-time decision support. I think we'll see a greater integration into symptom management, some early detection of complications, and longitudinal care coordination across our settings. I think nurses will continue to increasingly use AI to anticipate patient needs and prioritize care. I think the role of the nurse won't diminish. Rather, it will become more elevated in allowing them to practice to scope of practice." TS 19:58 Frith: "AI represents a meaningful opportunity to strengthen oncology nursing practice by reducing burden and enhancing the clinical insight. It needs to be a very thoughtful implementation. We talked about having strong governance and continued investment in the nursing workforce. I want to reinforce that oncology care remains deeply human, and AI should only be viewed as a tool that enables the nurses to do what they do best, which I feel is deliver safe, compassionate, and high-quality specialized care to our most vulnerable patients." TS 27:31

“

In this episode of the InspirED Podcast, Andrea De La Cerda explores one of the most overlooked drivers of fulfillment and success: where your energy goes. She explains how your attention becomes your habits, your habits become your life, and why burnout is often the result of energy leaks rather than a lack of strength. Andrea unpacks common patterns like people pleasing, perfectionism, overthinking, and living in survival mode, showing how they quietly redirect your energy away from the life you actually want. Through personal stories, practical reflection exercises, and an invitation to complete a three-day energy audit, this episode offers a powerful framework for creating a life built on intention, alignment, and purpose rather than obligation....CHAPTERS00:00 Introduction to Energy and Life02:42 Understanding Energy Investment05:14 The Impact of Relationships on Energy07:28 Finding Purpose Through Energy Alignment09:57 Shifting Attention for Future Transformation...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠The InspirED RewriteTAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

How do you build a single, standardized drug diversion program across a large health system when every hospital, infusion center, and outpatient location has developed its own processes?In this episode of Drug Diversion Insights, Terri welcomes Deepika Nayyar, Network Manager of Pharmacy Quality, Compliance, and Accreditation at Hackensack Meridian Health, to discuss the real-world challenges of implementing a system-wide diversion prevention program across diverse care settings.Deepika shares how her team evaluated existing practices, established baseline standards, and created a consistent approach to diversion prevention while recognizing the unique operational needs of inpatient hospitals, outpatient pharmacies, and infusion centers.The conversation also explores an often-overlooked area of diversion monitoring: medications with abuse potential that are not controlled substances. These medications frequently fall outside the capabilities of traditional diversion monitoring software, creating risks that require additional oversight, clinical expertise, and thoughtful auditing.In this episode, you'll learn:How to standardize a diversion program across multiple healthcare facilitiesWhy diversion monitoring differs between inpatient and outpatient settingsStrategies for monitoring medications with abuse potential beyond controlled substancesThe limitations of current diversion software and analyticsData elements that could improve diversion detectionHow medication safety and sterile compounding experience strengthen diversion prevention effortsPractical lessons from leading pharmacy quality, compliance, and accreditation across a large health systemWhether you're a pharmacy leader, diversion specialist, compliance professional, medication safety officer, or healthcare executive, this episode provides practical insights for building a stronger, more consistent diversion prevention program.Technology plays an important role—but successful diversion prevention still depends on strong processes, critical thinking, and a culture of accountability.More from Rxpert Solutions

Welcome back to the Law School Toolbox podcast! Today Alison is talking with the ABA's Managing Director of Accreditation and Legal Education about law school accreditation -- what's been happening in Texas and Florida, and what it means for current and prospective law students. In this episode we discuss: An introduction to our guest, Jennifer Rosato Perea What does law school accreditation actually mean? Changes to accreditation in Texas and Florida, and what they mean for students The portability of a law degree Choosing a law school in 2026 Resources: American Bar Association (https://www.americanbar.org/) Download the Transcript  (https://lawschooltoolbox.com/episode-565-law-school-accreditation-in-2026-a-conversation-with-jennifer-rosato-perea/) If you enjoy the podcast, we'd love a nice review and/or rating on Apple Podcasts (https://itunes.apple.com/us/podcast/law-school-toolbox-podcast/id1027603976) or your favorite listening app. And feel free to reach out to us directly. You can always reach us via the contact form on the Law School Toolbox website (http://lawschooltoolbox.com/contact). If you're concerned about the bar exam, check out our sister site, the Bar Exam Toolbox (http://barexamtoolbox.com/). You can also sign up for our weekly podcast newsletter (https://lawschooltoolbox.com/get-law-school-podcast-updates/) to make sure you never miss an episode! Thanks for listening! Alison & Lee

"Think about what organs lie in the radiation field, and anything that lies in that radiation field is likely going to have some potential temporary—hopefully temporary—side effects. If you think about the pelvis, the things that live in there are the bladder, urethra, some bowel, rectum, reproductive organs, skin, some lymph nodes. And so, all of those things could potentially have associated side effects," ONS member Kayla Kafka-Peterson, BSN, RN, ROCN™, nurse navigator and leader in the brachytherapy and peri-anesthesia programs at UCLA Health, in Los Angeles, CA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about radiation side effects in cancers of the pelvis. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 17, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to radiation to the pelvis. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Radiation Site-Specific Side Effects series Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles ONS Voice articles: Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: Nurse Navigation and Care During Brachytherapy for Cervical Cancer: 2025 ONS Bridge™ Session ONS ROCN™ Certification Review™ ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Genitourinary Distress: Common Side Effect Sexual Dysfunction: Common Side Effect Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Oncology Nursing Forum article: Effect of Foot Reflexology and Aromatherapy on Anxiety and Pain During Brachytherapy for Cervical Cancer ONS Guidelines™ and Symptom Management Resources: Radiodermatitis Radiation-Induced Diarrhea Brachytherapy Huddle Card American Brachytherapy Society American Society for Radiation Oncology (ASTRO) European Society for Radiotherapy and Oncology (ESTRO) GEC-ESTRO Committee International Gynecologic Cancer Society Nursing Certificate Program To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Brachytherapy is delivered two main ways. The most common is LDR and HDR. LDR stands for low-dose-rate radiation, which is the older type of brachytherapy, but it is still very much practiced today. And it is where we put radioactive seeds directly into the tumor or tumor resection bed, depending on what you're treating. And those pieces of radioactive material, such as iodine-125 or palladium-103, those will give off radiation over time and treat the area that they are in, and they will place more or less seeds into the tumor, depending on that patient's needs and their anatomy." TS 3:26 "The most common [side effect] for external beam is bladder irritation—cystitis. It can be some burning, some frequency, some urgency, and it can often mimic a UTI [urinary tract infection]. We also have to make sure our patients do not have a UTI. Most of the time they don't, but we don't want to miss that. Once a UTI has been ruled out, the mucosa in the bladder and the urethra, it has a very high cell turnover rate. And things with a high cellular turnover rate like mucosal linings, they respond to radiation very quickly. They also heal very quickly, but they start to break down quite quickly during radiation." TS 16:15 "For the bladder, some things that we can teach the patients … to keep their urinary system as comfortable as possible during treatment. We really encourage hydration because the more hydrated they are, the more diluted their urine will be and the less acidic it will be. As those tissues start to respond to the radiation, they will become, for lack of a better word, a little bit raw. And if you think of something acidic going on something that is raw, it's going to burn, and these patients do get burning. And so by promoting hydration, their urine becomes less acidic; it doesn't burn as much when they do urinate. And I find a lot of patients who are experiencing the urinary side effects, they don't want to drink because they're afraid to urinate. And it actually makes the burning worse because their urine gets ultra-concentrated." TS 22:29 "Anybody who has a vagina, who receives treatment to the pelvis—it doesn't matter if it's for vaginal cancer or if it's for bowel or rectal—if they have received radiation to the pelvis, they are at risk for vaginal stenosis and adhesions. And this, of course, can be more pronounced in patients who have a higher dose in the vagina or a larger surface volume of the vagina treated. But over time, that tissue, even long after radiation is done, will undergo late changes where they will have continued scar formation, and it starts to lose its elasticity and its functionality. And at times it can stick to itself, causing these adhesions." TS 28:15 "I think a common misconception is that you cannot safely work around radiation. That is something that I have heard a lot. In certain regions of the world, the nurses actually report that they have been having trouble getting good applicants because nobody wants to work in radiation because they think that you'll get radiated, that it's not safe. We've really tried to make radiation safety a big part of our teaching to show that actually, you can safely work around radiation with today's technology." TS 41:43

Unlike most nations, the United States eschews centralized control over its system of higher education in favor of a more decentralized “regulatory triad” of accreditation agencies, state licensing authorities, and certification by the U.S. Department of Education to participate in federal student aid programs. To qualify for federal student loans and grants, colleges and universities must be institutionally accredited by an Education Department-recognized accrediting agency. As gatekeepers of federal financial aid, accreditors have great sway over their institutions. President Trump issued an executive order on "Reforming Accreditation to Strengthen Higher Education," and the Education Department recently commenced negotiated rulemaking on new accreditation regulations and intends to publish a final rule by November 1, 2026.But what is the purpose of accreditation, and how much power do accreditors hold? What is the connection to federal funding, and how are determinations of "academic quality" made? Do the current accreditation processes and recognized agencies meet their aims? What is the role of the Department’s National Advisory Committee for Institutional Quality and Integrity in this process? What can the public expect to see in the Department’s new accreditation regulations? To what extent, if at all, can the Department use its recognition authority over accreditors effectively to address such topics as campus free speech, academic freedom, DEI, and other controversial issues? Join us for a discussion on the nuts and bolts of accreditation and what the current process means for the state of higher education in America today.Featuring:Robert S. Eitel, Co-Founder and President, Defense of Freedom InstituteJonathan Helwink, Principal, Helwink Legal Group, PLLCAdam Kissel, Visiting Lecturer in Formal Organizations, Trinity College(Moderator) Sarah Parshall Perry, Vice President & Senior Legal Fellow, Defending Education

In this episode of the InspirED Podcast, Andrea De La Cerda explores the hidden grief that comes from feeling like you don't truly belong. Through deeply personal stories from her family, marriage, and corporate leadership journey, she shares how years of adapting to meet other people's expectations led to self-abandonment rather than authentic connection. Andrea explains the difference between fitting in and belonging, why so many women confuse performance with acceptance, and how loneliness often stems from hiding who we really are. This episode is an invitation to stop earning approval, reconnect with yourself, and build a life where belonging begins from within....CHAPTERS00:00 Why We Long to Belong 02:30 When Belonging Feels Conditional 05:15 How Self-Abandonment Begins 08:48 Searching for Acceptance 11:42 Fitting In vs. True Belonging 15:18 The Loneliness of Performance 18:41 What If the Problem Isn't You? 21:30 Learning to Belong to Yourself 25:02 Four Questions to Help You Reconnect 29:12 Choosing Yourself First...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠The InspirED RewriteTAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Congresswoman Mary Miller returns to the show to expand on her viral hearing exchange, declaring that medical schools abandoning basic scientific truth for DEI ideology should lose their accreditation entirely. She confirms the Smithsonian is being restored under the Trump administration after reports of pride flags replacing American flags in exhibits, and updates listeners on House Republicans pushing to get the SAVE Act, requiring voter ID, through a resistant Senate. Miller doesn't hold back, calling out Democrats for demanding photo ID to attend their own events while fighting it at the ballot box. Truth, accountability, and election integrity — that's Congresswoman Mary Miller on The Marc Cox Morning Show. Hashtags: #MarcCoxMorningShow #StLouis #ConservativeTalk #MaryMiller #SAVEAct #VoterID #MedicalSchoolAccountability #Smithsonian #DEI #ElectionIntegrity #FaithFamilyFreedom

The UK's Professional Standards Authority (PSA) has introduced a new single set of standards that will be used to assess both professional regulators and accredited registers, replacing separate frameworks with a unified set of expectations. In this episode, host Line Dempsey speaks with Graham Mockler, Director of Regulation and Accreditation at the PSA, about the rationale behind this significant change and what it means for the future of regulatory oversight. They discuss the shift toward outcomes-focused regulation; the growing emphasis on governance, risk management, and organizational culture; and the importance of greater consistency across regulatory systems for strengthening public protection and public confidence. The conversation also explores the practical challenges of implementation, the role of collaboration in addressing regulatory gaps, and the measures that will determine whether the new framework achieves its intended impact. Transcript

Overview of Gestational Diabetes Evaluation and Credit:  Evaluation and Credit:  https://www.surveymonkey.com/r/medchat92 Target AudienceThis activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast explores the evolving landscape of perinatal diabetes care. Diabetes poses significant risks during pregnancy, delivery, and the postpartum period. Yet, many patients enter pregnancy without adequate metabolic control, and systemic barriers often prevent optimal care coordination. The clinical complexities of managing diabetes across the perinatal timeline, including preconception counseling, glycemic targets during pregnancy, delivery planning, and postpartum follow-up will be discussed. Objectives  1.     Define current clinical guidelines for the screening and diagnosis of gestational diabetes. 2.     Discuss the role of preconception counseling, including optimization of metabolic control and medication management in patients with or at risk for diabetes during pregnancy.  3.     Describe evidence-based pharmacologic management, including the use of insulin, for diabetes during and after pregnancy. 4.     Recognize the short- and long-term maternal and fetal risks associated with gestational diabetes.    ModeratorKris E. Barnsfather, M.D. Obstetrician and Gynecologist Women's Care Physicians of Louisville Norton Women's Care Louisville, KY SpeakerKristine Y. Lain, M.D. Maternal and Fetal Medicine Specialist Norton Children's Maternal – Fetal Medicine Louisville, KY   Planners, Moderator and Speaker Disclosure   The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose. Commercial Support   There was no commercial support for this activity.    Physician CreditsAccreditation  Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation  Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.     For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/References American Diabetes Association https://www.diabetes.org   Navigating Diabetes in Pregnancy: Critical Approaches to Mitigate Risks and Improve Outcomes for Mother and Child https://pubmed.ncbi.nlm.nih.gov/40137145/   Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025 https://pubmed.ncbi.nlm.nih.gov/39651985/   Date of Original Release | July 2026; Information is current as of the time of recording.  Course Termination Date | July 2029 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.  

"When we think of drug interactions, specifically, the National Cancer Institute actually defines this as a change in the way a drug acts in the body when taken with certain other drugs, herbals, or foods or when taken with certain medical conditions. Drug interactions may cause the drug to either be more or less effective or cause effects on the body that are not expected," Carissa Ganihong, PharmD, BCOP, oncology and bone marrow transplantation clinical pharmacist at Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about interaction pathways. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 30 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by July 10, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge related to drug interactions in oncology care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series ONS Voice articles: Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs? Pharmacogenomics Testing Helps to Ensure That Effective Therapy Is Safe Therapy Use of Herbal Products Carries Risk for Drug Interactions, but Patient–Clinician Knowledge, Communication Remain Low What the Research Says About Drug Interactions and Medical Cannabis ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) ONS Huddle Cards: DPYD Gene and DPD Enzyme Pharmacogenomics ONS Oral Anticancer Medication Toolkit American Journal of Nursing articles: Understanding Pharmacokinetics: Part1: Drug Absorption Understanding Pharmacokinetics: Part 2: Drug Distribution Understanding Pharmacokinetics: Part 3: Drug Metabolism Understanding Pharmacokinetics: Part 4: Drug Elimination Journal of Nuclear Medicine Technology articles: Pharmacology, Part 1: Introduction to Pharmacology and Pharmacodynamics Pharmacology, Part 2: Introduction to Pharmacokinetics ClinPGx To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "One of the most notable food interactions that interacts with many different medications is actually grapefruit or grapefruit juice. This is known to be a very strong CYP3A4 inhibitor. … A lot of medications are metabolized through the CYP3A4 pathway. By inhibiting the effect of these enzymes, that can actually increase and significantly increase the concentrations of these therapies. It's not an interaction that's just limited to grapefruit. I would say grapefruit being in the food interaction is kind of one of the most well-known, but it can also be seen with other foods as well, like pomegranate juice or a very specific type of orange called Seville oranges. And this is really just due to the presence of a substance called furanocoumarins." TS 6:12 "There have been a pretty large number of genes identified that are responsible for coding some of those common enzyme families that I had been discussing, some of those CYP450 enzymes, but other enzymes as well that are important for drug metabolism. Based on the type of gene, there could be some different categories where patients are normal metabolizers, intermediate metabolizers, or poor metabolizers. There are some other categories as well based on the type of gene we're looking at. And that can ultimately impact the way you are able to metabolize drugs." TS 15:56 "Another common [geneotypic variation] that we always think about in oncology is G6PD, where if someone has G6PD deficiency, these patients can be at greater risk of hemolytic anemias when receiving certain types of therapies. Dapsone and rasburicase are just a couple that have been associated with this risk." TS 17:50 "One of the big concerns is always polypharmacy. Our patients truly can be on a lot of medications. In the field that I work in, transplant, patients automatically from their transplant are on many, many different medications that can potentially predispose them to side effects. … But I think when it comes to the many drug interactions that may flag in these situations, we really have to look at the patient as a whole. Like, how long have these patients been on these therapies? Are they having side effects? Have they been on the combination for a very long time now? So I think that not just looking at the drug reference and seeing that there are like 10 different interactions flagged, but really assessing your patient as a whole can be very important—just because real-world practice, of course, is not black and white. It's often very gray, so it's just important to use clinical judgment in those scenarios." TS 26:10

On the July 10 edition: Georgia gets more federal aid for Hurricane Helene recovery; A brush fire continues to burn on Georgia's coast; And a new exhibit by artist Bobbi Johnson opening today in Milledgeville looks at how hard times shapes who we are. 

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with personal stylist Lizette Hendricks to challenge one of the biggest misconceptions women have about fashion: that clothing should fix their bodies. Lisette shares her philosophy of using style to honor a woman's natural features rather than hide or change them. Together, they explore body harmony, seasonal color analysis, style myths, wardrobe overwhelm, and the emotional connection many women have with clothing. Through practical advice and personal insight, this conversation invites women to stop chasing trends and start dressing in a way that reflects their authentic selves with confidence....CHAPTERS 00:00 Meet Lizette Hendricks 01:45 How Lizette Became a Personal Stylist 03:23 Why Traditional Fashion Advice Falls Short 05:11 Creating a Safe Space for Style 07:14 Body Harmony, Color, and Personal Style 11:15 Why Style Is About Authenticity 13:00 Stop Dressing to Fix Your Body 17:10 The Freedom of Dressing as Yourself 18:38 Understanding Body Types and Color Seasons 24:40 Common Style Myths Debunked 27:52 Simplifying Your Wardrobe with Confidence...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Connect with Lizette Andrea De La Cerda⁠⁠Business Audit⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Cameron is joined by Tom Terranova, CEO of QUAD A, and they discuss the critical theme of compliance in the medical aesthetics industry. They explore the evolving landscape of regulations, the importance of accreditation, and how practices can enhance patient safety and trust through compliance. They highlight the need for a structured approach to compliance, emphasizing that it is not merely a checkbox but a continuous process of improvement and accountability. Tom shares insights on how QUAD A supports practices in achieving and maintaining high standards, ultimately benefiting both providers and patients.Cameron and Tom talk about the evolving landscape of medical aesthetics, focusing on the importance of patient trust, compliance, and accreditation. They explore the common deficiencies in medical practices, the accreditation process, and the potential impact of AI on healthcare. They also emphasize the need for practices to adapt to changing regulations and patient expectations while maintaining high standards of care. Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:Compliance is essential for safety and regulation in medical aesthetics.The wellness industry is at a pivotal moment for maturation.Patients should be treated as individuals, not just consumers.Accountability and continuous improvement are key aspects of compliance.A compliant practice is characterized by thoughtful and intentional operations.Standards for compliance are evolving as the industry grows.Optimizing operations is as important as meeting compliance standards.Patients value impartial accreditation as a sign of quality.Compliance should be viewed as an ongoing process, not a one-time checklist.Practices should aim to compete on quality rather than just price. Patients prioritize safety, results, compliance, and trust in their healthcare.The rise in popularity of aesthetic treatments has led to increased adverse events.Accreditation significantly boosts patient trust and confidence in medical facilities.Many patients remain unaware of the benefits of elective wellness treatments.Documentation is the most common deficiency in medical practices.The accreditation process typically takes around five months for facilities.Accreditation may soon become a standard expectation in the industry.Legislation regarding medical aesthetics is on the horizon.AI has the potential to enhance compliance but must be used cautiously.Practices need to differentiate themselves to thrive in a saturated market.Medical Millionaire: The Blueprint for Scaling a World-Class Medical Aesthetics PracticeWelcome to Medical Millionaire, the go-to podcast for forward-thinking Medspa owners, Medical Aesthetics leaders, Plastic Surgery & Dermatology practices, Concierge Wellness clinics, and Elective Healthcare entrepreneurs who are ready to scale with intention and operate like a true, high-performing business.If you're building, growing, optimizing, or preparing to exit your aesthetics or wellness practice, this show is your competitive advantage.Hosted by Cameron Hemphill Your Guide to Sustainable, Scalable Growth Your host, Cameron Hemphill, is one of the most trusted growth strategists in Medical Aesthetics and Elective Wellness.With over 10 years in the industry, Cameron has helped scale 1,000+ practices and more than 2,300 providers, working alongside the most recognized KOLs, national brands, EMRs, tech companies, and private equity groups, shaping the future of aesthetics. From marketing to operations, from finance to leadership, Cameron brings a real-world, data-driven perspective on what it takes to turn a practice into a powerful business engine.What This Podcast Is All About: Each episode takes you behind the scenes of the fastest-growing practices in the country, revealing the systems, strategies, and mindset required to win in today's Medical Aesthetics landscape.Expect tactical insights, step-by-step frameworks, and conversations with:Industry thought leadersTop injectors & medical directorsEMR & tech innovatorsOperations expertsMarketing strategistsPrivate equity & M&A advisorsWellness and longevity pioneersThis is where aesthetics, business, technology, and wellness converge. What You'll Learn on Medical Millionaire Every week, you'll access expert guidance to help you scale profitably and predictably, including:Marketing & Brand PositioningCRM + Lead Management SystemsPatient Acquisition & ConversionEMR Optimization & Tech Stack ArchitectureSales Psychology & Consultation MasteryFinance, KPIs, and Practice EconomicsOperational Workflows & AutomationIndustry Trends Backed by Real Benchmark DataPatient Retention & Lifetime Value ExpansionMindset, Leadership & Team DevelopmentWhether you're opening your first location or running a multi-million-dollar enterprise, you'll gain the clarity and direction to grow with confidence. A Show Designed for Every Stage of Practice Growth Medical Millionaire breaks down the journey into four essential stages, showing you exactly how to move from one to the next:Startup – Build the foundation and attract your first wave of patientsGrowth – Scale revenue, expand services, and strengthen operationsOptimize – Increase efficiency, margins, and customer experienceExit – Prepare your practice for maximum valuation and acquisitionIf You're Ready to Grow, This Is Where You Start. Tune in weekly for actionable insights, expert interviews, and the exact playbooks high-performing practices use to dominate their markets. This is the podcast for Medspa owners who want more than a job; they want a scalable, profitable, industry-leading business. Welcome to Medical Millionaire.Let's build your practice into the empire it deserves to be.

In this episode of Why Distance Learning, your hosts talk again with Michael Barbour — the most-cited researcher in K-12 online and distance learning — about what it would actually take to fix how teachers are prepared to teach online, and why thirty years of K-12 virtual learning hasn't produced that change yet. Drawing on his 2024 paper with Charles Hodges, Michael lays out six concrete steps — two focused on building the research base, four focused on teacher preparation programs — and explains why none of it happens without explicit mandates from states and accreditation bodies. The assumption under examination: that teacher prep programs will gradually incorporate online pedagogy on their own as demand grows. The evidence suggests they won't, for the same reason they never properly integrated technology in the first place.Together, the hosts and Michael explore the structural reasons teacher preparation programs can't make room for online pedagogy without a mandate, even when they want to. They dig into a counterintuitive finding from Newfoundland and Labrador — where students with K-12 online learning experience actually performed worse in college online courses than their peers, not because online experience is harmful, but because of how that particular program's heavy synchronous structure coddled students in ways that didn't transfer. They examine what the research actually shows about online learning and mental health (short version: the modality isn't the problem, and during the pandemic, logging into school may have been the most normal part of a child's day). And they work through the affordances and tradeoffs of synchronous versus asynchronous instruction — a framework any practitioner can apply immediately. Michael closes with the two big questions currently driving his research: where is the field of K-12 online learning thirty years in, and how much of what gets regulated in the US is driven by ideology rather than evidence?Key topics:Six-step framework for reforming online teacher preparation (Barbour & Hodges, 2024)Why teacher prep programs don't change without state or accreditation mandatesThe Newfoundland counterintuitive finding: when prior online experience hurtsSite-based facilitators / e-deans and the role of on-site support in distance programsSynchronous vs. asynchronous instruction: affordances, tradeoffs, and how to chooseOnline learning and student mental health: what the research actually showsGovernance and regulation of K-12 online learning in the US vs. other jurisdictionsLinks & Resources:Michael Barbour's website: michaelbarbour.comBarbour, M. K., & Hodges, C. B. (2024). Preparing teachers to teach online: Steps for teacher education. Open Praxis. https://openpraxis.org/articles/10.55982/openpraxis.16.4.727Barbour, M. K., Moore, S., & Veletsianos, G. (2023). Online/remote learning and mental health. https://touroscholar.touro.edu/tucse-pubs/29/Digital Learning Collaborative / Community for Advancing Digital Learning (DLAC): Research agenda report and special issue of the Journal of Online Learning Research https://www.deelac.com/wp-content/uploads/2025/10/DLAC-Research-Agenda-Phase-2-Final-1052025.pdfGuest Bio: Michael BarbourMichael Barbour is widely cited as the most prolific researcher in K-12 online and distance learning. His work spans student success and persistence in virtual environments, teacher preparation for online instruction, and the governance and regulation of K-12 online programs across jurisdictions. He is currently focused on building a research agenda for the field and examining how political ideology shapes online learning policy in the United States compared to other countries. Barbour holds a faculty position and has previously held posts at Wayne State University, among others.About the Hosts: Seth Fleischauer is the founder of Banyan Global Learning and host of Why Distance Learning. Through Banyan, he designs live virtual programs that connect K-12 classrooms to global peers and expert facilitators — building the kind of structured, human-centered distance learning the podcast explores. See https://banyangloballearning.com/programs/global-cohortsTami Moehring and Allyson Mitchell work with CILC, the Center for Interactive Learning and Collaboration, to help educators implement high-quality live virtual learning experiences across grade levels. Discover more at CILC.org.

"What I appreciate about our patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia is the consideration that they receive a cancer diagnosis, and the best thing for them to do is actually nothing. There is a large population of patients that we don't recommend any type of treatment. We recommend that they establish care with an oncologist and that they have a relationship with those care teams," ONS member Caitilin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about an overview of CLL for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 3, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge of the diagnosis and management of chronic lymphocytic leukemia. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 256: Cancer Symptom Management Basics: Hematologic Complications ONS Voice articles: Compensation Funds Curb Financial Burden for Certain Exposure-Related Cancers Infection Prevention for Oncology Nurses Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment Patient Stress Linked to More Advanced Leukemia Patients With CLL Report Worse QoL and Other Factors Clinical Journal of Oncology Nursing articles:  Care Coordination: Overcoming Barriers to Improve Outcomes for Patients With Hematologic Malignancies in Rural Settings Pseudohyperkalemia in Chronic Lymphocytic Leukemia: An Often Overlooked Clinical Entity Richter Transformation Arising From Chronic Lymphocytic Leukemia ONS book: Site-Specific Cancer Series: Leukemia (first edition) Hematology, Cellular Therapy and Stem Cell Transplantation Learning Library ONS Biomarker Database ONS clinical practice resource: Genomics Taxonomy Blood Cancer United: Chronic Lymphocytic Leukemia: In Detail CLL Society: Patient Education Toolkit Lymphoma Research Foundation: Lymphoma and CLL Publications National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the common risk factors are environmental exposures, occupational exposures, and chemical exposures. For example, in certain farming communities where there are pesticides, that can definitely contribute to the risk of developing CLL. There's some consideration for high levels of radon exposure or exposure to Agent Orange. So our veterans, both from the Vietnam War but also more recently in Iraq. There's definitely a consideration that those types of exposures increase the risk of developing CLL." TS 3:01 "Generally, the average age of diagnosis for CLL is in the seventh decade of life. But over 90% of people are diagnosed at age 50 and above. So, this tends to be a diagnosis in the six or seventh decade of life. It's extremely rare in children, although it has been observed, and it's twice as likely to develop in men than it is compared to women. And then individuals who are White are more frequently affected by CLL than other racial or ethnic groups, followed by people of color. And that includes Black, Hispanic, and Native American individuals, but it's rarer in Asian populations." TS 9:33  "There's a lot of adjustment and coping with a new diagnosis. When we think about the diagnostic approach, we get a lot of information that's incredibly valuable and helps us really to pivot and guide patients as to where they need to go and how we can best support them. We've had well-established studies that look to say, 'If we were to treat patients earlier or have different thresholds for consideration for treatment, do patients do better?' ... I think it's really great that we can actually guide patients in a much more precise way, that you don't need any type of therapy at this point, and it may change and evolve in the future." TS 20:29 "I have some patients that are doers and they want to do something, so this active surveillance or watch and wait really paralyzes their coping. And so they want to do something. Oftentimes, that's really when I pull in some integrative strategies and say exercise is always going to be beneficial. The more active you are, the more physically fit you are. If you really want to do something, make sure that you stay hydrated, that you eat well, and you're engaged in a physical activity that you enjoy and can be consistent with." TS 32:37 "I think another piece that we don't often discuss is around the immunoglobulins and the immune system, but CLL has a pretty significant impact on immune dysfunction. And so patients with CLL, even if they are not on any type of active treatment, their immune system doesn't necessarily function fully. And so they're more likely to develop some upper respiratory infections or more easily develop the flu or coronavirus. ... Often times, we think a lot about supporting patients to get vaccines and to have early evaluation if those symptoms develop because you're more likely to develop upper respiratory infections. I think there's a component around immune dysfunction that I think is really valuable for people to understand that it's not contingent upon the treatment. It's contingent upon the disease and mechanistically, how the B cells are dysfunctional and don't provide that immunity that otherwise would be in a healthy B cell." TS 42:54

In this episode of the InspirED Podcast, Andrea De La Cerda explores why so many women struggle with negotiation and why the challenge has less to do with confidence than with lifelong conditioning. She explains how women are often taught to prioritize likability over self-advocacy, making it difficult to negotiate compensation, pricing, boundaries, and opportunities. Andrea reframes negotiation as a conversation about alignment rather than confrontation and shares practical strategies to communicate value with greater clarity, confidence, and authority. Whether you're negotiating your salary, setting business rates, or advocating for your role, this episode offers actionable insights to help you stop shrinking and start leading....CHAPTERS00:00 Why Women Hesitate to Negotiate 02:12 The Conditioning Behind Self-Advocacy 05:04 Why Likability Feels Safer Than Respect 07:46 The Hidden Cost of Staying Quiet 10:18 Negotiation Is About Alignment, Not Conflict 12:30 Four Practical Ways to Start Negotiating 16:42 Building Confidence Through Self-Advocacy 19:03 The Long-Term Impact of Speaking Up...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Neal Shah, Shareholder, Polsinelli, speaks with Scott Strickland, Attorney, Hall Render Killian Heath & Lyman PC, about what the Center for Medicare and Medicaid Innovation (CMMI) has been doing in the health care space. They discuss examples of some of the more prominent CMMI models, the distinction between CMMI models and traditional CMS models, health care industry responses to CMMI models, what the next generation of CMMI models looks like, and the different approaches that CMMI has taken regarding provider payment obligations. Scott co-authored an article for Health Law Connections on this topic. From AHLA's Regulation, Accreditation, and Payment Practice Group.Watch this episode: https://www.youtube.com/watch?v=bQysibh0rhYRead Scott's Health Law Connections article: https://www.americanhealthlaw.org/content-library/connections-magazine/article/34b68117-81e2-4c7f-9258-245198a69107/CMMI-and-the-Next-Generation-of-Alternative-Paymen Learn more about AHLA's Regulation, Accreditation, and Payment Practice Group: https://www.americanhealthlaw.org/practice-groups/practice-groups/regulation-accreditation-and-payment Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

Send us Fan MailWelcome to The BTA Podcast.  In these podcasts we will endeavour to share our thoughts, concerns, optimism and build those all-important human connections with our Partners, Members and Guests.Episode Overview:The latest edition of the BTA Pulse reflects on the momentum following the Business Travel Show, where the BTA launched its new Accreditation programme — a significant step forward in recognising professionalism, standards and best practice across the business travel sector. Andrew and Clive discuss the strong response from members, buyers and suppliers, alongside the wider conversations shaping the industry.The episode explores the BTA's ongoing work bringing all industry sectors together, from aviation and rail to hotels, sustainability and talent development. Key topics include improving industry processes, strengthening collaboration, supporting future travel professionals through Generation BTA, and addressing challenges around safety, technology and changing travel requirements. The latest BTA Pulse highlights the association's continued commitment to driving positive change across the business travel ecosystem.You can subscribe to this podcast by searching 'BusinessTravel360' on your favorite podcast player or visiting BusinessTravel360.comThis podcast was created by The BTA and edited & distributed by BusinessTravel360.  For more information about The BTA visit TheBTA.org.ukSupport the show

"There are a huge array of medical dynamics that people endure, and when they leave a lasting impact, a word that we don't use widely enough is the word 'trauma.' There's an entire category of phenomena in the medical arena that are, in fact, traumatic. One way we know that these experiences are traumatic is that we know that huge portions of people who experience things like cancer do indeed develop problems like [post-traumatic stress disorder]," James C. Jackson, PsyD, research professor at Vanderbilt University Medical Center in Nashville, TN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about understanding medical trauma in oncology. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 26, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge of medical trauma and its effects on patients with cancer, caregivers, and healthcare professionals. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 315: Processing Grief as an Oncology Nurse Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care Episode 276: Support Young Families During a Parent's Cancer Journey Episode 257: Redefining the Bell: The Ethics of Hope for Oncology Nurses and Patients Episode 103: What Oncology Nurses Need to Know to Support Caregivers ONS Voice articles: 'Between Two Kingdoms' Gives Us a Glimpse Into How Patients and Families Experience Malignancy AYA Cancer Survivors Experience Five Times Higher Depression Rates Than Individuals Diagnosed at Older Ages From Stigma to Support: Changing the Cancer Conversation Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD Moral Injury and Trauma in Nursing Trauma-Informed Care Provides Person-Centered Support for Patients During Deep Distress When the Story Ends, Cancer Does Not Win: Reframing Death in Terminal Cancer Care Word Choice Matters When Caring for Patients With Cancer ONS course: ONS Psychosocial Dimensions of Cancer Care™  Clinical Journal of Oncology Nursing articles: Psychosocial Barriers to Care: Recognizing and Responding Through a Trauma-Informed Care Approach Trauma-Informed Care Addressing the Mental and Emotional Needs of Patients With Cancer Oncology Nursing Forum articles: Post-Traumatic Distress and Symptom Experience in Patients With Head and Neck Cancer–Related Tracheostomy and Family Caregivers The Effect of Neuroticism, Fear of Progression, and Self-Efficacy on Post-Traumatic Growth in Patients With Lung Cancer Undergoing Chemotherapy Reclaiming Your Life From Medical Trauma by James C. Jackson To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Many people have a notion about what medical trauma is, but perhaps they lack a definition. I use a definition that is deliberately broad because I think it is better to be inclusive than exclusive. A medical trauma to me is a medical experience or a medical encounter that basically leaves a mark. It leaves an emotional mark, and that mark is significant enough to disrupt your daily life." TS 2:06 "When somebody develops a life-threatening illness—let's say cancer—it's not their problem only. It's very much a family problem. It affects any manner of people. There is literature that says that family members of people with life-threatening conditions often have rates of PTSD that are every bit as high as the patients do. There's also literature that says that if we can identify this issue as a family problem—a family challenge, not just an individual challenge—then very often that patient is going to do better." TS 8:23 "We just need to make space for people to feel however they feel. And we need to emphasize, I think, that in some ways, even though there's no cancer on the scan, cancer casts a long shadow in the lives of people, which is why when patients after cancer see their primary care provider, when they come back for a checkup with oncology, we need to continue this conversation of 'How is your mental health? Are you okay? How's your anxiety? How are you managing?' … We need to be really curious and kind, and we need to query people about how they're doing, even if officially they don't have cancer." TS 16:20 "Trauma-informed care has become a bit of a buzzword in our culture. But when it is engaged correctly, I think it's really important. And I think in a nutshell, what it means is that as providers, we need to recognize that some situations and circumstances are likely to be traumatic, and we need to pivot and engage people differently now that we know that. Specific features of trauma-informed care might be we're really going to value your emotional safety. We're going to emphasize that. We are going to emphasize boundaries. We are going to ask your permission instead of telling you how to do things. We are going to be really attentive to the language we use to engage you because we're aware of there might be things about your situation that are really triggering." TS 28:15 "I think one [misconception] certainly is that it is only afflicting and affecting people who are frail or weak—not very strong. That's emphatically not true. But that's a popular misconception—that if I'm strong enough, if I'm resilient enough, this experience will not be traumatic to me. It's just not true. Medical trauma doesn't just happen in emotionally weak people. Medical trauma can impact people of all sorts." TS 33:42 "The other misconception, I think, is that there is no hope for people in the throes of medical trauma. I'm not advocating 'hopium,' It's a term that was coined, I think, during the pandemic. I don't think that living with medical trauma is all rainbows and unicorns and shiny things. But the truth is, if you get the treatment that you need, you can find a way to thrive with medical trauma even as you're impacted by medical trauma. This, this 'both-and-ness' is really true. You can both be adversely affected and you can even find some beauty in your struggle. Both can be true." TS 34:13 "I wish people understood that there is a name for this phenomenon. We're naming it here today medical trauma. Not everyone who has cancer has medical trauma—not even close—but there are many people who do. And I think many of those people, they don't quite have a name for it. And when I introduce this name for it—trauma—many of them say, 'Oh, my gosh, that makes so much sense. I didn't quite understand why I was struggling so much with this. I didn't quite understand why it casts such a long shadow in my life. I didn't really understand why I was having panic attacks every time I had to get another scan at the oncology office to see if my breast cancer had returned. Now I understand. Now I understand it's because it was trauma.'" TS 35:09

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with Ashley Crossan to discuss her remarkable journey from chronic illness to holistic healing practitioner. After years of battling serious health challenges, including chronic illness, long-haul COVID, and Lyme disease, Ashley began exploring holistic health, emotional healing, and energy work in search of answers beyond symptom management. Together, they explore the connection between emotional well-being and physical health, the role of unresolved stress and trauma in the body, and how healing can become a catalyst for personal growth and purpose. This conversation offers an inspiring perspective on resilience, wellness, and finding meaning through life's most difficult experiences....CHAPTERS 00:00 Meet Ashley Crossan 01:37 Ashley's Journey Through Chronic Illness 04:48 Long-Haul COVID, Lyme Disease, and Healing 06:15 Discovering Holistic Health and Energy Work 08:05 Understanding Energy and Emotional Healing 10:41 The Connection Between Pain and Unresolved Emotions 13:48 Why More People Are Exploring Alternative Healing 16:10 Stories of Transformation and Recovery 19:59 From Skeptic to Believer 23:51 The Science Behind the Mind-Body Connection 26:03 Healing Beyond Symptom Management 27:20 How to Connect with Ashley...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Connect with AshleyAndrea De La Cerda⁠⁠Business Audit⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

In this episode, ASOPRS Immediate Past President, Dr. Wendy Lee, moderates a candid roundtable with Drs. Don Kikkawa, John Holds, Evan Black, and Reza Vagefi, as they discuss ACGME accreditation of fellowship training. The panel weighs external validation, standardized training, and the potential for a new ABO subspecialty certification in the setting of ACGME requirements and some program director concerns about those requirements. Both ACGME accreditation of fellowships and participation in ABO Continuing Certification are two key components of an ABMS-compliant certification. Whether you're a member or simply invested in the future of oculofacial plastic surgery, this conversation is essential listening.

"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN®, nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 220: Oncologic Emergencies 101: Febrile Neutropenia and Sepsis Clinical Journal of Oncology Nursing articles:  Exploring Experiences of Bereaved Caregivers of Older Adult Patients With Acute Myeloid Leukemia Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Oncology Nursing Forum article: An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies ONS book: BMTCN® Certification Review Manual (second edition) ONS course: Psychosocial Dimensions of Cancer Care™  ONS Learning Libraries:  Survivorship Learning Library Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship Care Plan Huddle Card American Association of Colleges of Nursing End-of-Life Nursing Education Consortium (ELNEC) American Cancer Society: Living As a Myelodysplastic Syndrome Survivor American Society of Hematology Aplastic Anemia and MDS International Foundation: MDS Toolkit Blood Cancer United: Myelodysplastic Syndromes Family Caregiver Alliance HealthTree Foundation Inspire: MDS Support and Discussion Community Myelodysplastic Syndromes Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "When our higher-risk patients have disease-related progression, their [malignancy] can transform to AML. And we know this occurs in about one-third of our patients and is one of the most serious late effects. Even in lower-risk disease, we have this worsening marrow failure with or without increasing blast, where [patients] may have just started out with anemia, then they also develop neutropenia and thrombocytopenia. And as those counts worsen, we usually know that their disease is progressing." TS 2:47 "The golden rule is looking at the blood count but also looking at the patient and how they're doing over time. The backbone of MDS monitoring is the complete blood cell count with the differential. What you're looking for is trends over time. How many units of blood are they receiving, what threshold are you going to transfuse them at, and how many units of blood are they getting at a time? ... And then paying attention to the absolute neutrophil count for infection risk. [Another] really important piece of when you look at the differential with patients is seeing if they have any abnormal cell counts. Do they have circulating blasts? Are those monocytes going up? If you start to see blasts circulating or increasing monocytes, then their disease could be changing, even if they have low-risk disease." TS 15:58 "For lower-risk disease, we're paying more attention to their quality of life, how the patient's tolerating therapy, trying to help them stay safe over the long haul, and starting them on iron chelation if it matches that patient and they can have access to those drugs. ... For higher-risk disease, if the patient's goal is to be cured and not to progress to AML, you want to get them to transplant if that's [also] one of their goals. If they do evolve into AML, try and see what treatment matches best for them." TS 22:28 "You want to start early for patients who have febrile neutropenia—that's really important when a patient is an hour or two away from a center where they can get started on antibiotics. So, you have to think outside the box. What can we do to keep them safe? ... I know this group in Alaska that's in our advisory meetings and they try to facilitate transportation to Seattle. That's the closest academic center to them. Collaborating with telemedicine appointments, starting earlier, developing that strong relationship with patients, and contacting them between visits [can help patients living in rural areas]." TS 25:22 "I think the biggest [psychosocial challenge] I see is a lot of unmet anxiety and depression counseling. A lot of times, [patients are] losing their place in their family because they're the ones that need all the help now. Also, the uncertainty that goes along with the diagnosis. There is communication skills counseling, and End-of-Life Nursing Education Consortium (ELNEC) has a lot of training for communication skills and how to really talk to patients. Not that we take the place of a psychologist, but just being able to talk to somebody can go a long way. And if we can get training for that, we can help more patients." TS 31:15

On today's program, the Assemblies of God is disputing liability in abuse cases — claiming local church autonomy shields it from the Daniel Savala sex abuse lawsuits. And, a movement to void nondisclosure agreements in cases of child sexual abuse is gaining ground — on both the local and national levels. The laws limiting NDAs are called Trey's Laws. We'll take a look. Plus, Southwestern Baptist Theological Seminary, has, after years of turmoil, officially regained its accreditation status. But first, Sean Feucht Ministries is fighting back against a lawsuit — and it’s using the First Amendment to do it. It argues a $250,000 lawsuit filed against it should be dismissed because of what’s called the “church autonomy doctrine.” It protects religious institutions from lawsuits that would require courts to wade into matters of faith and doctrine. The producer for today's program is Jeff McIntosh. We get database and other technical support from Stephen DuBarry, Rod Pitzer, and Casey Sudduth. Writers who contributed to today's program include Kim Roberts, Stacey Horton, Marci Seither, Makella Knowles, and Jessica Eturralde. Until next time, may God bless you.  

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with Gina Fedeli, founder of P3 Transformation, to explore the powerful connection between identity and leadership. Drawing from her experience leading large teams in male-dominated industries and advising founders and CEOs, Gina shares how self-awareness, values alignment, emotional intelligence, and communication shape the way leaders show up and influence others. Together, they discuss the CEO-COO partnership, intuition in leadership, understanding the whole person, and why meaningful leadership starts with knowing yourself first. This conversation offers valuable insight for entrepreneurs, executives, and emerging leaders who want to lead with greater authenticity, clarity, and impact....CHAPTERS00:00 Meet Gina Fedeli 02:20 Leading in Male-Dominated Industries 04:05 Learning to Meet People Where They Are 05:58 Why Great Leaders Understand the Whole Person 09:16 Intuition, Self-Awareness, and Leadership 13:36 Emotional Intelligence in Business 16:44 The CEO and COO Partnership 18:33 Leadership, Identity, and Founder Growth 22:21 Values Alignment and Organizational Culture 26:59 What Meaningful Leadership Looks Like 29:45 Advice for Women Leaders...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠P3 Transformation Gina FedeliAndrea De La Cerda⁠Business Audit⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

"Until immunomodulators, patients [with myeloma] did not have a great overall survival rate. But when we introduced lenalidomide, we started seeing our patients have life expectancies between five and seven years—which was unheard of prior to these immunomodulators going forward. I think it's promising and allows patients to have quality of life versus therapy of life," ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about immunomodulators. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 12, 2027. Daniel Verina is on the speakers' bureau for Johnson & Johnson, GlaxoSmithKline, and Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome:  Learners will report an increase in knowledge about the use of immunomodulators to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 386: Interprofessional Navigation and the Oral Anticancer Medication Care Compass Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy ONS Voice articles: Maintain Oral Adherence With ONS Guidelines™ Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Sexual Considerations for Patients With Cancer Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum articles: Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Symptom Intervention resource: Peripheral Neuropathy Risk Evaluation and Mitigation Strategies (REMS) Lenalidomide Pomalidomide Thalidomide International Myeloma Foundation: Using Immune Therapy to Fight Multiple Myeloma International Myeloma Society Multiple Myeloma Research Foundation: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We definitely want the diagnosis of multiple myeloma before initiating these drugs. We're going to look at serum protein electrophoresis. We want to make sure that we know the patient has serum free light chains and myeloma proteins to really confirm their disease. Plus, a bone marrow biopsy." TS 7:21 "Each immunomodulator has slightly different side effects. Thalidomide's biggest side effects are constipation, weakness, fatigue, somnolence, peripheral neuropathy, mood swings, hand tremors, and depression. With each generation, less of the side effects actually occurred. Most of lenalidomide's side effects, not discounting the deep vein thrombosis, are pancytopenia—the neutropenia, the anemia, and the thrombocytopenia. [The side effects] are very similar in pomalidomide." TS 15:40 "The REMS program is critical for oral immunomodulator therapies—thalidomide, pomalidomide, and lenalidomide. It was developed due to the risk of developing embryofetal toxicities. ... It is mandatory testing and counseling, so all females of reproductive potential must have two negative pregnancy tests prior to starting the therapy and then monthly pregnancy tests while on the therapy alone. Again, they must use two forms of effective contraceptives or abstain from heterosexual sex four weeks prior, during, and after. And the same thing for men. I focus on that because males may say, 'I have a vasectomy.' These therapies tend to bind to the semen. So, males must still use a latex or synthetic condom during any sexual contact with a female of reproductive potential, even if they did have a vasectomy." TS 18:31 "The capsule itself cannot be chewed, crushed, or opened. I bring that up because as healthcare professionals, we have educated our patients. If it's difficult to swallow capsules or tablets, we've always said to them, 'Oh, don't worry, just crush it into applesauce or open it up and sprinkle it on your mashed potatoes.' But because of this embryofetal toxicity, I advise my patients not to open the capsule. If they can't swallow it for any reason, they have a sore throat or they're just unable to, then [we tell them] to hold the therapy and then call us." TS 22:49 "We spoke about three generations already, but there's actually a fourth generation [of immunomodulators]. They're called cereblon E3 ligase modulators(CELMoDs). They're still in clinical trials but really showing promise in the therapy of myeloma. They're showing very good affinity to cereblons, just like the immunomodulators do. I think, in all cancer therapies, as newer generations come out or newer therapies move forward, some of the older generations might move aside, but they get integrated later on. So I don't think [immunomodulators] will disappear totally, but they will probably be modified." TS 36:39

"Radiation therapy is often extremely well tolerated in colorectal cancer. Technology has really changed things. But location of the tumor can affect side effects, such as radiation dermatitis. If a patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case," ONS member Lorraine Drapek, DNP, FNP-BC, AOCNP®, nurse practitioner in the Department of Radiation Oncology at Massachusetts General Hospital in Boston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation side effects in colorectal cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 5, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat colorectal cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer High-Fiber Diet Reduces Diarrhea in Colorectal Cancer Survivors Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects Increasing Incidence of Colorectal Cancer in Younger Adults Is a Call to Action for Oncology Nurses Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin Oncology Nurses Are Key in Sexual Health Conversations With Minority Women Sexual Considerations for Patients With Cancer The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS ROCN™ Certification Review™ Clinical Journal of Oncology Nursing articles: Sexual Dysfunction: Common Side Effect Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Physical Activity: A Systematic Review to Inform Nurse Recommendations During Treatment for Colorectal Cancer ONS Learning Libraries: Colorectal Cancer Radiation Advanced Practitioner Society for Hematology and Oncology American Society for Radiation Oncology American Society of Clinical Oncology Clinical Practice Guidelines Colontown Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "In recent years, there has been more nonsurgical management of rectal cancer, especially in what we call the low-lying population. This is the population of patients who would likely end up with a permanent colostomy because their cancer is so low in terms of being close to or involving the anal verge. There is now a regimen where these patients can get their chemotherapy followed by their chemoradiation and then be monitored on close surveillance without surgery." TS 2:23 "Another assessment would be to assess what effects have they had from their chemotherapy that they're bringing with them. FOLFOX-based treatment is commonly used, and the platinum therapy oxaliplatin often causes peripheral neuropathy. What is the patient having? What are those symptoms like? Are they having peripheral neuropathy? If they are that is likely not going to get better or improve during their whole course of radiation. In fact, sometimes when oxaliplatin therapy stops, the peripheral neuropathy can get worse as patients are going through other treatments." TS 5:42 "If the patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case. And then proactively minimizing radiation dermatitis effects, such as keeping the area clean, good washing of the area, and prophylactically starting them on or having someone start them on steroid creams a couple of times a day to minimize that radiation dermatitis effect in the long run." TS 7:25 "I have a sexual health clinic for women with these effects. It's very important as nurses that if you can develop the comfort to ask patients about their sexual activity—it's hard, but it really needs to be done. And I will tell you that the healthcare providers are not doing it. They don't have time, and like us as nurses, we don't get this in school, and neither do they. The other providers don't get it in school either, but it's important. Patients are getting more and more worried about their sexual health. They're coming to us at a younger age, and this is really, really important to address." TS 15:35 "I would say that working with your advanced practice providers and education for advanced practice providers has definitely been focusing on [sexual health] more. Your PAs and your NPs—I think they're going to have the ears and the wherewithal to be able to be your allies and colleagues in this. By and large, it's my APP colleagues and nursing that I talk to the most about this. … Again, it's not an easy thing to bring forward, having dilators in place. But I will tell you in the department that I work in, it was me and couple of nurses who pushed this issue with the physicians for two years and finally got it put in place. It can be done. There's a lot more centers out there doing that." TS 21:51